Xcell Therapeutics Passes KOSDAQ Technology Evaluation
Xcell Therapeutics passes KOSDAQ technology evaluation…claims preliminary listing in September
“Entering the global market in earnest after listing on KOSDAQ”
Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ.
![[Infographic] Môi trường nuôi cấy thế hệ thứ 3: CD AOF (Chemically Defined & Animal Origin Free)](https://biogroupvietnam.com/wp-content/uploads/2026/02/infographic-moi-truong-nuoi-cay-the-he-thu-3-cd-aof-200x150.png)
